Skip to main content

Research Digest — Not Medical Advice: BodySignals summarises published research for informational purposes. It is not a healthcare provider and does not replace professional medical advice. If you believe you are having a medical emergency, call emergency services immediately. Full disclaimer

Research digest — not medical advice. Full disclaimer · How we rate evidence

Sleep Hub/Supplements

Apigenin

Chamomile extract

C - Moderate EvidenceOverall rating for this intervention. See the benefits list below for per-claim ratings.

Overview

A bioflavonoid found in chamomile. Popularised by Andrew Huberman but backed by limited direct human trials as a standalone supplement.

How it works

Binds weakly and selectively to benzodiazepine receptors in the brain, producing a mild anxiolytic and sedative effect without the dependence profile of benzodiazepines.

Benefits

  • Sedation: mild sedative effect via benzodiazepine receptors.

    C

Dosage

50 mg before bed

Safety Profile

Risk Level
low

Contraindications

  • Pregnancy
  • Blood thinner medications (theoretical interaction)

Research Summary

Popularised by Huberman. Limited human trials of the isolated compound. Chamomile tea itself has better (though still modest) evidence.

Sources

Last updated: 2026-04-10

Sidebar

Medical Disclaimer

This is a research summary, not medical advice. Body Signals is an independent research digest — it summarises published research for informational purposes and is not a healthcare provider. Supplements like melatonin, valerian, and magnesium can interact with prescription medications — check with your doctor or pharmacist before starting any supplement. Chronic insomnia may indicate an underlying condition (sleep apnoea, thyroid dysfunction, depression) and warrants a medical evaluation.

Need professional guidance?

If sleep issues persist despite lifestyle changes, a sleep specialist or your family doctor can help rule out underlying conditions.

Learn about sleep specialists

Quick Facts

Category
Supplements
Evidence Rating
Risk Level
low
Last Updated
2026-04-10